Decentralized Care And Telehealth Will Advance Dialysis Adoption

Published
12 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$25.75
48.4% undervalued intrinsic discount
15 Aug
US$13.29
Loading
1Y
33.4%
7D
3.8%

Author's Valuation

US$25.8

48.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on08 Aug 25
Fair value Increased 5.10%

Analysts have raised their consensus revenue growth forecast for Outset Medical from 11.8% to 12.6% per annum, offsetting a higher discount rate, and resulting in an increased fair value price target from $24.50 to $25.75. What's in the News Outset Medical raised its 2025 revenue guidance to $122 million-$126 million from $115 million-$125 million.

Shared on01 May 25
Fair value Increased 11%

Shared on24 Apr 25
Fair value Decreased 10%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 7.55%